Paid social creates demand among people who are not searching yet, but in cardiometabolic you cannot target the condition, creative must account for real stigma, and the platform will optimize for cheap sign-ups that never enroll. We build paid social that finds the right members without prohibited targeting, uses reassuring creative to convert, and optimizes for enrolled members rather than clicks.
You cannot target the condition, so careless targeting either underperforms or gets you banned
Meta and other platforms prohibit targeting based on health conditions, so you cannot simply build a diabetes audience, and teams that try either get campaigns rejected or risk account suspension. The workaround is not a targeting trick but a creative-and-signal strategy that lets the right people self-select, and most performance marketers coming from other categories do not know how to run that. Treating cardiometabolic like any other consumer audience is how you burn budget on the wrong people or lose the account entirely.
Creative that bluntly names the condition pushes away the members it needs to attract
People managing diabetes or cardiometabolic risk carry stigma, and an ad that loudly labels the viewer as sick triggers avoidance rather than interest. Performance teams used to blunt, direct-response hooks import them here and wonder why nothing converts, when the problem is that the creative made the viewer feel exposed. In this category the emotional register of the creative is a performance variable, not a branding nicety, and getting it wrong quietly caps your entire program.
The platform chases cheap sign-ups that never turn into members
Meta will efficiently deliver whatever conversion you feed it, and if that is a cheap lead or sign-up, it will find you people who fill out the form and never enroll or activate. In cardiometabolic's long funnel, that means an account that looks great on cost-per-lead and quietly destroys unit economics. Optimizing to the top-of-funnel event because it is the easy one to track is one of the most common and expensive mistakes in the category.
Creative fatigue sets in quickly, and you have no engine to replenish it
Paid social burns through creative quickly, and cardiometabolic teams that treat creative as an occasional project rather than a continuous pipeline watch performance decay as the same few ads fatigue. Because the creative constraints here are tighter – stigma-aware, claim-compliant – the pool of usable concepts is smaller, so fatigue bites harder. Without a systematic testing and production engine, the account plateaus and CAC creeps up no matter how well the targeting and optimization are set.
We begin by creating an acquisition approach that finds the right members without prohibited targeting. Because you cannot target the condition, we develop creative and signals that help the right people self-select, apply broad-but-guided audiences, and use the platform's optimization alongside honest conversion feedback to identify your members. Most performance marketers lack this core competency in cardiometabolic, and doing it well is what keeps the account effective without getting banned.
Next, we rebuild creative around the emotional reality of the condition. We create hooks and messaging that normalize and reassure instead of labeling and exposing, because the creative's register is a performance lever in this category. We test to discover what genuinely converts a stigma-sensitive viewer, which is generally quite different from the blunt direct-response playbook that succeeds in other categories.
We correct the outcome the platform optimizes for, sending back enrolled-member data rather than cheap sign-ups so Meta learns to locate people who truly become members. Platforms reliably pursue whichever event you prioritize, so we ensure it chases enrollment quality rather than form-fills – a change that typically reshapes the entire account and its true CAC.
We establish an always-on creative engine, since paid social declines without one and tighter constraints here cause fatigue to hit sooner. We create a structured pipeline of stigma-aware, claim-compliant concepts with a disciplined testing cadence, allowing the account to keep uncovering new winners instead of stalling on a few worn-out ads.
Our difference is that we operate paid social around enrolled members and unit economics, connected to your analytics and wider marketing, rather than functioning as an agency chasing cost-per-lead. We link the program to actual members, keep it within platform and claim rules, and supply the clean conversion data required for honest optimization.
You cannot target diabetes on Meta – which means that in cardiometabolic, creative becomes the targeting. The right ad helps the right member self-select; the wrong ad either underperforms or gets your account banned.
We deliver a paid-social engagement designed for a regulated, stigmatized, long-funnel category. Phase one covers strategy and instrumentation: we create the self-selection approach that reaches members without prohibited targeting and connect enrolled-member conversions back to the platform. The right optimization goal and compliant targeting must be in place before spend scales.
Phase two focuses on creative and testing. We establish a stigma-aware creative engine and disciplined testing cadence because creative is the key lever in this category, and it fatigues quickly. This is how the account discovers what truly converts a cautious viewer.
The last phase scales using the right signal. Once the platform is optimizing for enrolled members and supported by a creative pipeline, we scale what succeeds against your unit economics and eliminate what does not. Instead of reporting cost-per-lead like an agency, we judge the account by cost per enrolled member and cohort quality, because a low-cost lead that never enrolls is a leak, not an outcome.
During the first thirty days, we establish the compliant targeting approach, connect the enrolled-member conversion, and launch initial stigma-aware creative tests. Within weeks, the account is safely reaching the right members and optimizing for the outcome that counts. Correcting targeting and the optimization goal at the same time is the quickest way to reset an underperforming account.
By sixty days, the creative engine is operating and the platform is retraining around enrollment quality, shifting budget toward the audiences and concepts that generate members. Your team includes a paid-social operator backed by creative and analytics support; we need access to your ad accounts and enrollment data, along with compliance coordination on creative claims.
By ninety days, the program is scaling against the enrolled-member signal, supported by a consistent creative pipeline and connected to your broader analytics. We maintain a weekly cadence for optimization and creative testing, plus a monthly readout centered on cost per enrolled member and cohort quality.
Engagements usually last three to six months to establish the creative engine, retrain the account, and validate the economics, with many clients extending into ongoing management. The objective is a paid-social program that compliantly reaches stigma-sensitive members, converts them into enrolled members, and avoids plateauing on fatigued creative.
If your diabetes & cardiometabolic health company needs paid social leadership, we should talk.
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
The engagement has a fixed monthly fee that is separate from media spend and includes the creative pipeline this category requires, a genuine cost that most teams underestimate. We do not charge a percentage of ad spend because that would incentivize spending rather than acquiring quality members.
Fresh targeting and creative may change performance in the first few weeks, but the platform requires sufficient enrolled-member conversions to retrain, so the complete quality improvement develops across the ninety-day window. We assess results through cost per enrolled member and cohort quality, which shift more meaningfully than early cost-per-lead.
We work as part of your team, managing the account and testing cadence while either producing creative ourselves or guiding your creative resources into the pipeline the account requires. We need access to your ad accounts and enrollment data, plus compliance coordination around creative claims. Your team remains connected to creative learnings so successful angles inform the rest of your marketing.
The standard paid-social agency focuses on cost-per-lead and charges based on ad spend; we focus on enrolled members and use a flat fee so our incentives align with your unit economics. We also understand how to reach cardiometabolic members without using prohibited targeting that can get accounts banned. The result is a compliant program that uses stigma-aware creative to acquire real members, not a cheap-lead machine.
We combine creative and signal strategy to help the right people self-select, using broad-but-guided audiences and honest conversion feedback so the platform's optimization can find your members. Creative essentially performs the targeting in this category, making its quality and compliance especially important. The approach reaches appropriate members while staying within platform rules instead of risking suspension through prohibited health targeting.
We track cost per enrolled, eligible member and the downstream quality of each cohort, reconciling results with your system of record instead of platform-reported leads. Doing so requires sending the true enrollment outcome back to the platform so it can optimize properly. Since the program centers on the conversion that matters, ROI is evaluated by members acquired and their retention, not inexpensive top-of-funnel events.
The ideal fit is a Series A through growth-stage diabetes or cardiometabolic company with a validated funnel and enough enrollment volume to give the platform data to learn from. If you have not established that a member's value exceeds their acquisition cost, demand-creation spending is too early. If your account repeatedly encounters targeting rejections, creative fatigue, or low-cost leads that never enroll, this is the solution.
Tuesday, September 22, 2026
Frank Growth – Episode 238 – The Best Kept Secret Sport with Ozge Erturk
Tuesday, September 15, 2026
Frank Growth – Episode 237 – Stop Buying Users Who Leave with Michelle Matthews
Tuesday, September 8, 2026
Frank Growth – Episode 236 – Turn Marketers Into AI Strategists with Elyssa Steiner
Tuesday, June 16, 2026
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy
Ready to unlock your growth?
Book Free Call